Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 778

1.
2.

Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.

Li JM, Zhang W, Su H, Wang YY, Tan CP, Ji LN, Mao ZW.

Int J Nanomedicine. 2015 Apr 23;10:3147-62. doi: 10.2147/IJN.S67146. eCollection 2015.

3.

Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier.

Wang J, Dou B, Bao Y.

Mater Sci Eng C Mater Biol Appl. 2014 Jan 1;34:98-109. doi: 10.1016/j.msec.2013.08.035. Epub 2013 Sep 4.

PMID:
24268238
4.

Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.

Park K, Lee MY, Kim KS, Hahn SK.

Biomaterials. 2010 Jul;31(19):5258-65. doi: 10.1016/j.biomaterials.2010.03.018. Epub 2010 Apr 7.

PMID:
20378167
5.
6.

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.

Huang H, Yu H, Tang G, Wang Q, Li J.

Biomaterials. 2010 Mar;31(7):1830-8. doi: 10.1016/j.biomaterials.2009.11.012. Epub 2009 Nov 25.

PMID:
19942284
7.

Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.

Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A.

J Gene Med. 2010 Mar;12(3):287-300. doi: 10.1002/jgm.1431.

PMID:
20052738
8.

Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.

Ping Y, Liu C, Zhang Z, Liu KL, Chen J, Li J.

Biomaterials. 2011 Nov;32(32):8328-41. doi: 10.1016/j.biomaterials.2011.07.038. Epub 2011 Aug 15.

PMID:
21840593
9.

The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.

Jiang HL, Xu CX, Kim YK, Arote R, Jere D, Lim HT, Cho MH, Cho CS.

Biomaterials. 2009 Oct;30(29):5844-52. doi: 10.1016/j.biomaterials.2009.07.017. Epub 2009 Jul 28.

PMID:
19640582
11.

Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.

Zou S, Cao N, Cheng D, Zheng R, Wang J, Zhu K, Shuai X.

Int J Nanomedicine. 2012;7:3823-35. doi: 10.2147/IJN.S29328. Epub 2012 Jul 18.

12.

Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.

Darvishi MH, Nomani A, Amini M, Shokrgozar MA, Dinarvand R.

Int J Pharm. 2013 Nov 18;456(2):408-16. doi: 10.1016/j.ijpharm.2013.08.069. Epub 2013 Sep 3.

PMID:
24012865
13.

A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.

Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U, Czubayko F, Aigner A.

J Control Release. 2006 May 15;112(2):257-70. Epub 2006 Mar 6.

PMID:
16574264
14.

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.

Shen M, Gong F, Pang P, Zhu K, Meng X, Wu C, Wang J, Shan H, Shuai X.

Int J Nanomedicine. 2012;7:3319-32. doi: 10.2147/IJN.S32900. Epub 2012 Jul 2.

15.

Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.

Xia W, Wang P, Lin C, Li Z, Gao X, Wang G, Zhao X.

J Control Release. 2012 Feb 10;157(3):427-36. doi: 10.1016/j.jconrel.2011.10.011. Epub 2011 Oct 18.

PMID:
22036880
16.

Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.

Jiang G, Park K, Kim J, Kim KS, Hahn SK.

Mol Pharm. 2009 May-Jun;6(3):727-37. doi: 10.1021/mp800176t.

PMID:
19178144
17.

Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy.

Liu L, Liu X, Xu Q, Wu P, Zuo X, Zhang J, Deng H, Wu Z, Ji A.

Int J Nanomedicine. 2014 Jul 29;9:3509-26. doi: 10.2147/IJN.S63717. eCollection 2014.

18.

Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.

Yin JJ, Sharma S, Shumyak SP, Wang ZX, Zhou ZW, Zhang Y, Guo P, Li CZ, Kanwar JR, Yang T, Mohapatra SS, Liu W, Duan W, Wang JC, Li Q, Zhang X, Tan J, Jia L, Liang J, Wei MQ, Li X, Zhou SF.

PLoS One. 2013 May 2;8(5):e62289. doi: 10.1371/journal.pone.0062289. Print 2013.

19.

Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.

Lee MY, Park SJ, Park K, Kim KS, Lee H, Hahn SK.

ACS Nano. 2011 Aug 23;5(8):6138-47. doi: 10.1021/nn2017793. Epub 2011 Jul 8.

PMID:
21739990
20.
Items per page

Supplemental Content

Write to the Help Desk